Results 271 to 280 of about 348,919 (331)

Effect of low-molecular-weight heparin on gestational sac and embryo development, and miscarriage prevention for recurrent spontaneous abortion. [PDF]

Am J Transl Res
Zhang F, Chi L, Diao YH.
europepmc   +1 more source

CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism.

Oncol Res Treat
Sinn M, Lohneis A, Mohamed O, Roderburg C, Hellmann M, Südhoff T, Christoph DC, Krziwanie A, Heinz J, Semrau S, Schlenska-Lange A, Ettrich TJ, Trappe RU, Striefler JK, Pelzer U, Wernecke KD, Riess H.   +16 more
europepmc   +1 more source

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Journal of Clinical Oncology, 2018
Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients.
Annie M Young, Andrea Marshall, Janet A Dunn   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Heparin/Low-molecular-weight-heparins

Reactions Weekly
semanticscholar   +6 more sources

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Chest, 2001
J. Hirsh, T. Warkentin, S. Shaughnessy, Sonia S Anand, J. Halperin, R. Raschke, C. Granger, E. Ohman, J. Dalen   +8 more
semanticscholar   +1 more source

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Chest, 2004
J. Hirsh, R. Raschke
semanticscholar   +1 more source

Low-Molecular-Weight Heparins

Archives of Internal Medicine, 1993
HEARIN WAS first described in 1916 by McLean 1 who was working in the laboratory of Dr William Howell. McLean was given the assignment to extract thromboplastin from various animal tissues. Ironically, rather than isolating procoagulant thromboplastin, he was successful in extracting an anticoagulant. Following his discovery, heparin was found to be an
openaire   +2 more sources

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Chest, 1998
J. Hirsh, T. Warkentin, R. Raschke, C. Granger, E. Ohman, J. Dalen   +5 more
semanticscholar   +1 more source

Low Molecular Weight Heparin

Thrombosis and Haemostasis, 1993
openaire   +2 more sources